Results demonstrated that CD155 expression was much higher in mesenchymal-molecular subtype and classical subtype gliomas compared to that in the other two subtypes based on the Rembrandt dataset (Supplementary Figure 1C). The gene discussed is PVR; the disease is central nervous system cancer.